Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review

Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review

Background: Cardiac rhabdomyomas (CRs) are the most common cardiac tumors in newborns. Approximately 80–90% of cases are associated with tuberous sclerosis complex (TSC). In selective cases, Everolimus has resulted in a remarkable tumoral regression effect in children with TS. The optimal dosage for...

Full description

Bibliographic Details
Main Authors: Luisa Federica Nespoli, Elena Albani, Carla Corti, Luigina Spaccini, Enrico Alfei, Irene Daniele, Gian Vincenzo Zuccotti, Gianluca Lista, Valeria Calcaterra, Savina Mannarino
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Pediatric Reports
Subjects:
cardiac rhabdomyoma
tuberous sclerosis
everolimus
neonate
low dose
Online Access:https://www.mdpi.com/2036-7503/13/1/15

Internet

https://www.mdpi.com/2036-7503/13/1/15

Similar Items